To collect further evidence for the tumor specificity of the two cryptic peptides RVYLDIVTPK (IFT81) and RLSSSLPSR (ST3GAL6), we evaluated their immunogenicity applying an in vitro priming assay (Figure 4). The gene discussed is ST3GAL6; the disease is neoplasm.